Clinical trial reportJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPublished
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
- Published
- Topic
- Disease research
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Mutation; Female; Male
- PubMed ID
- 42061572
- Added to directory
- Source checked